Quick Takeaways:
- The FDA has issued an Emergency Use Authorization (EUA) for Bimectin (ivermectin) Injection to prevent New World screwworm (NWS) infestations in cattle when administered within 24 hours of birth, at castration, or when a wound appears.
- Bimectin, a generic version of Ivomec, becomes another authorized option for protecting cattle against NWS myiasis. The FDA said expanding access to both pioneer and generic products could reduce dependence on a single manufacturer.
- Bimectin is available over the counter and is sponsored by Bimeda Animal Health. Producers must follow a 35-day slaughter withdrawal period, and the product is not authorized for use in lactating dairy cows or calves intended for veal production.
Why It Matters?
The FDA’s Emergency Use Authorization for Bimectin (ivermectin) Injection adds a second over‑the‑counter option for preventing New World screwworm in cattle, alongside the pioneer Ivomec product, and is intended to reduce reliance on a single manufacturer during the ongoing outbreak. By expanding access to both generic and pioneer products, the move can improve availability and pricing for producers who must treat calves at birth, at castration, or when wounds appear, while maintaining food‑safety safeguards such as the 35‑day slaughter withdrawal and restrictions on use in lactating dairy cows and veal calves.
Source: Globenewswire
